WRONG. Read the transcript.
Why does Bassam receive outrageous interest payments as the company's biggest creditor?
First of all, I am not a creditor of the company. I am not actually holding any debt for the company. I converted my line of credit in 2015 as $0.40 a share. I believe you are confusing me with the notes we had from the institutions, which carried high interest. I am not happy to pay interest, but being an OTC company, it is not always easy to raise money and take a nonconvertible debt to acquire assets. And this is what we did when we acquired the beyond human platform when we took the note that had 20% interest. And I have to say, I am happy we took that note because it is that platform that Beyond Human sales and marketing platform that while the turnaround platform for the company who took us from $750,000 in revenues in 2015 to close to $5 million in revenues in 2016. So, I am very happy that we did that and we achieved that goal.
